Article
Pyrazinamide Susceptibility Is Driven by Activation of the SigE-Dependent Cell Envelope Stress Response in Mycobacterium tuberculosis.
mBio - 22 Feb 2021
Thiede Joshua M, Dillon Nicholas A, Howe Michael D, Aflakpui Ranee, Modlin Samuel J, Hoffner Sven E, Valafar Faramarz, Minato Yusuke, Baughn Anthony D
Abstract excerpt
Pyrazinamide (PZA) plays a crucial role in first-line tuberculosis drug therapy. Unlike other antimicrobial agents, PZA is active against Mycobacterium tuberculosis only at low pH. The basis for this conditional drug susceptibility remains undefined. In this study, we utilized a genome-wide approach to interrogate potentiation of PZA action. We found that mutations in numerous genes involved in central metabolism...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
